470 related articles for article (PubMed ID: 15026085)
61. Prolactin synthesis and secretion by human breast cancer cells.
Ginsburg E; Vonderhaar BK
Cancer Res; 1995 Jun; 55(12):2591-5. PubMed ID: 7780973
[TBL] [Abstract][Full Text] [Related]
62. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
Kavarthapu R; Tsai Morris CH; Dufau ML
Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
[TBL] [Abstract][Full Text] [Related]
63. [Action mechanism of pituitary hormones--receptor and signal transduction--prolactin].
Aono T; Yokoyama Y
Nihon Rinsho; 1993 Oct; 51(10):2631-5. PubMed ID: 8254931
[TBL] [Abstract][Full Text] [Related]
64. Discovery of the improved antagonistic prolactin variants by library screening.
Liu Y; Gong W; Breinholt J; Nørskov-Lauritsen L; Zhang J; Ma Q; Chen J; Panina S; Guo W; Li T; Zhang J; Kong M; Liu Z; Mao J; Christensen L; Hu S; Wang L
Protein Eng Des Sel; 2011 Nov; 24(11):855-60. PubMed ID: 21954059
[TBL] [Abstract][Full Text] [Related]
65. Breast Cancer and Prolactin - New Mechanisms and Models.
Clevenger CV; Rui H
Endocrinology; 2022 Oct; 163(10):. PubMed ID: 35922139
[TBL] [Abstract][Full Text] [Related]
66. Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cells.
Philips N; McFadden K
Cancer Lett; 2004 Mar; 206(1):63-8. PubMed ID: 15019161
[TBL] [Abstract][Full Text] [Related]
67. Expression of prolactin and its receptor in human breast carcinoma.
Reynolds C; Montone KT; Powell CM; Tomaszewski JE; Clevenger CV
Endocrinology; 1997 Dec; 138(12):5555-60. PubMed ID: 9389544
[TBL] [Abstract][Full Text] [Related]
68. Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.
Ogueta S; Muñoz J; Obregon E; Delgado-Baeza E; García-Ruiz JP
Mol Cell Endocrinol; 2002 Apr; 190(1-2):51-63. PubMed ID: 11997178
[TBL] [Abstract][Full Text] [Related]
69. A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: the complex is not the prolactin receptor.
Lorenson MY; Ueda EK; Chen KE; Walker AM
Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E585-94. PubMed ID: 22205628
[TBL] [Abstract][Full Text] [Related]
70. Prolactin receptors in human breast cancer cells in long-term tissue culture.
Shiu RP
Cancer Res; 1979 Nov; 39(11):4381-6. PubMed ID: 227585
[TBL] [Abstract][Full Text] [Related]
71. Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
Hachim IY; Hachim MY; Lopez VM; Lebrun JJ; Ali S
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):238-45. PubMed ID: 26317306
[TBL] [Abstract][Full Text] [Related]
72. Characterization of prolactin receptors and their distribution among American and Israeli women with breast cancer: implications for prediction of hormonal dependency and treatment.
Ben-David M; Kadar T; Wittliff J; Biran S; Schally A
Biomed Pharmacother; 1988; 42(2):101-9. PubMed ID: 3167163
[TBL] [Abstract][Full Text] [Related]
73. Immunoregulation of autocrine prolactin: suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown.
Xu D; Lin L; Lin X; Huang Z; Lei Z
Cell Immunol; 2010; 263(1):71-8. PubMed ID: 20307875
[TBL] [Abstract][Full Text] [Related]
74. Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.
Kavarthapu R; Dufau ML
Oncotarget; 2016 Oct; 7(40):65602-65613. PubMed ID: 27564112
[TBL] [Abstract][Full Text] [Related]
75. In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells.
Ramamoorthy P; Sticca R; Wagner TE; Chen WY
Int J Oncol; 2001 Jan; 18(1):25-32. PubMed ID: 11115535
[TBL] [Abstract][Full Text] [Related]
76. Antagonism of prolactin binding by cyclosporine A on MCF7 breast tumour cell line.
Bernard DJ; Maurizis JC; Sauvezie B; Bignon YJ; Chassagne J; Chollet P; Plagne R
Anticancer Res; 1991; 11(6):2147-51. PubMed ID: 1776854
[TBL] [Abstract][Full Text] [Related]
77. New concepts in prolactin biology.
Bernichtein S; Touraine P; Goffin V
J Endocrinol; 2010 Jul; 206(1):1-11. PubMed ID: 20371569
[TBL] [Abstract][Full Text] [Related]
78. Prolactin and murine mammary tumorigenesis: a review.
Welsch CW; Nagasawa H
Cancer Res; 1977 Apr; 37(4):951-63. PubMed ID: 191183
[TBL] [Abstract][Full Text] [Related]
79. Reconstituted normal human breast in nude mice: estrogen and progesterone receptors regulation.
Yang J; Guzman R; Nandi S
In Vivo; 2001; 15(3):239-44. PubMed ID: 11491019
[TBL] [Abstract][Full Text] [Related]
80. Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer.
Nitze LM; Galsgaard ED; Din N; Lund VL; Rasmussen BB; Berchtold MW; Christensen L; Panina S
Breast Cancer Res Treat; 2013 Nov; 142(1):31-44. PubMed ID: 24146212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
